Design, Synthesis, and Evaluation of NO-Donor Containing Carbonic Anhydrase Inhibitors To Lower Intraocular Pressure

Qinhua Huang(Pfizer (United States)), Martin P. Edwards(Pfizer (United States)), Brian D. Patterson(Pfizer (United States)), Saurabh Mehta(Pfizer (United States)), Hovhannes J. Gukasyan(Pfizer (United States)), Eugene Rui(Unknown), Dac M. Dinh(Pfizer (United States)), Jennifer Lafontaine(Pfizer (United States)), Paul Richardson(Pfizer (United States)), David A. Rewolinski(Pfizer (United States)), Morena Cobbs(Pfizer (United States))
Journal of Medicinal Chemistry
February 28, 2015
10.1021/acs.jmedchem.5b00043
Cited by 30

Related Papers

Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
|Journal of Medicinal Chemistry|2011|924
Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations
|Journal of Medicinal Chemistry|2014|587
Using the Golden Triangle to optimize clearance and oral absorption
|Bioorganic & Medicinal Chemistry Letters|2009|382
Lipophilic Efficiency as an Important Metric in Drug Design
|Journal of Medicinal Chemistry|2018|340
Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis
|Bioorganic & Medicinal Chemistry Letters|2009|269